I agree that this site is using cookies. You can find further informations here.
X
Stauffer, Frédéric
67  results:
Search for persons X
?
1

Identification of NVP-CLR457 as an Orally Bioavailable Non-..:

Fairhurst, Robin A. ; Furet, Pascal ; Imbach-Weese, Patricia...
Journal of Medicinal Chemistry.  65 (2022)  12 - p. 8345-8379 , 2022
Link: https://doi.org/10.1021/..
 
?
2

DOT1L inhibition is lethal for multiple myeloma due to pert..:

Dafflon, Caroline ; Gaulis, Swann ; Barys, Louise...
Oncotarget.  11 (2020)  11 - p. 956-968 , 2020
Link: https://doi.org/10.18632..
 
?
3

Development of a Robust Synthesis of Dactolisib on a Commer..:

Baenziger, Markus ; Pachinger, Werner ; Stauffer, Frédéric.
Organic Process Research & Development.  23 (2019)  9 - p. 1908-1917 , 2019
Link: https://doi.org/10.1021/..
 
?
4

New Potent DOT1L Inhibitors for in Vivo Evaluation in Mouse:

Stauffer, Frédéric ; Weiss, Andreas ; Scheufler, Clemens...
ACS Medicinal Chemistry Letters.  10 (2019)  12 - p. 1655-1660 , 2019
Link: https://doi.org/10.1021/..
 
?
5

Discovery of Potent, Selective, and Structurally Novel Dot1..:

Möbitz, Henrik ; Machauer, Rainer ; Holzer, Philipp...
ACS Medicinal Chemistry Letters.  8 (2017)  3 - p. 338-343 , 2017
Link: https://doi.org/10.1021/..
 
?
6

Optimization of a Fragment-Based Screening Hit toward Poten..:

Scheufler, Clemens ; Möbitz, Henrik ; Gaul, Christoph...
ACS Medicinal Chemistry Letters.  7 (2016)  8 - p. 730-734 , 2016
Link: https://doi.org/10.1021/..
 
?
7

Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether..:

Fairhurst, Robin A. ; Marsilje, Thomas H. ; Stutz, Stefan...
Bioorganic & Medicinal Chemistry Letters.  26 (2016)  8 - p. 2057-2064 , 2016
Link: https://doi.org/10.1016/..
 
?
8

Identification of a 5-[3-phenyl-(2-cyclic-ether)-methylethe..:

Stauffer, Frédéric ; Cowan-Jacob, Sandra W. ; Scheufler, Clemens.
Bioorganic & Medicinal Chemistry Letters.  26 (2016)  8 - p. 2065-2067 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Discovery and Pharmacological Characterization of Novel Qui..:

Hoegenauer, Klemens ; Soldermann, Nicolas ; Stauffer, Frédéric...
ACS Medicinal Chemistry Letters.  7 (2016)  8 - p. 762-767 , 2016
Link: https://doi.org/10.1021/..
 
?
10

Discovery of Novel Dot1L Inhibitors through a Structure-Bas..:

Chen, Chao ; Zhu, Hugh ; Stauffer, Frédéric...
ACS Medicinal Chemistry Letters.  7 (2016)  8 - p. 735-740 , 2016
Link: https://doi.org/10.1021/..
 
?
11

A General Strategy for Targeting Drugs to Bone:

Jahnke, Wolfgang ; Bold, Guido ; Marzinzik, Andreas L....
Angewandte Chemie International Edition.  54 (2015)  48 - p. 14575-14579 , 2015
Link: https://doi.org/10.1002/..
 
?
12

Gezielte Anreicherung von Wirkstoffen am Knochen am Beispie..:

Jahnke, Wolfgang ; Bold, Guido ; Marzinzik, Andreas L....
Angewandte Chemie.  127 (2015)  48 - p. 14783-14787 , 2015
Link: https://doi.org/10.1002/..
 
?
13

Discovery of Novel Allosteric Non‐Bisphosphonate Inhibitors..:

Marzinzik, Andreas L. ; Amstutz, René ; Bold, Guido...
ChemMedChem.  10 (2015)  11 - p. 1884-1891 , 2015
Link: https://doi.org/10.1002/..
 
?
14

New aromatase inhibitors from the 3-pyridyl arylether and 1..:

Stauffer, Frédéric ; Furet, Pascal ; Floersheimer, Andreas.
Bioorganic & Medicinal Chemistry Letters.  22 (2012)  5 - p. 1860-1863 , 2012
Link: https://doi.org/10.1016/..
 
?
15

Imidazo[4,5-c]quinolines as inhibitors of the PI3K/PKB-path..:

Stauffer, Frédéric ; Maira, Sauveur-Michel ; Furet, Pascal.
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  3 - p. 1027-1030 , 2008
Link: https://doi.org/10.1016/..
 
1-15